Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subc...
FDA Recall #D-0554-2025 — Class II — July 18, 2025
Product Description
Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034.
Reason for Recall
Lack of Processing Controls.
Recalling Firm
AEQUITA PHARMACY — Kirkland, WA
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
236 vials
Distribution
MA
Code Information
All Lots within expiry
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated